Malvern, UK — Malvern Instruments (Malvern, Worcestershire, UK) has been successful in securing £3 million support from the UK Government’s Regional Growth Fund (RGF) that will lead to the creation of 47 new jobs in the UK over the next five years. Malvern develops, manufactures and markets materials and biophysical characterization systems. These are used […]
Austin, Texas –- VUV Analytics announced today that it closed a $5.8 million Series A equity investment to fund the launch of its laboratory-scale molecular spectroscopy instruments business. The investment was led by S3 Ventures. In conjunction with the financing, S3’s Managing Director, Brian R. Smith, will join the company’s board of directors.“We are really […]
RYE, NY -– SFW Capital Partners, a specialized private equity firm that invests with management in mid-sized companies providing analytical tools and related services, today announced an investment in Essen BioScience, Inc. SFW is partnering in this investment with Essen’s co-founders, Kirk Schroeder and Brad Neagle, who serve as the current President and Vice-President of […]
Eagle, an expert provider of bioinformatics software and services across a wide range of the life science and other sectors, has won a Small Business Research Initiative (SBRI) competition which will see the company further develop its technology for genomic data management and analysis. The competition was funded by the Department of Health, through the […]
SISCAPA Assay Technologies, Inc. today announced that it closed a Series A equity financing round aimed at funding the company’s R&D efforts, expanding its catalog of assays, and driving its commercialization activities. The financing was led by the company’s angel investors and included a small number of new, private investors. “Adoption of our technology by […]
BERWYN, Pa. AMETEK, Inc. (AME) today announced its Board of Directors has approved a 50% increase in the quarterly cash dividend on common stock to $0.09 per share from $0.06 per share. The dividend is payable on June 30, 2014 to shareholders of record on June 16, 2014. This dividend increase will raise the annualized […]
OMAHA, Neb. — Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that its shares of common stock have been approved for uplisting to the NASDAQ Capital Market. Effective Friday, May 9, 2014, the stock will […]
The Endress+Hauser Group increased its net sales by more than 7 percent to over 1.8 billion euros last year. While foreign exchange rates slowed growth, acquisitions, particularly in the field of analytics, provided a boost. Besides venturing into new markets, the change at the head of the Group was the dominant feature of 2013. The […]
ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that on May 1, 2014, the Company received approximately $6.4 million in equity financing. The funds were raised from current long-term investors in the Company and will be used for funding product […]
Santa Clara, California — ProteinSimple announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of its common stock. All of the shares to be sold in the proposed offering will be offered by ProteinSimple. The number of shares to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
